Moreover, enzalutamide induced PCAT6 also promotes PCa cell proliferation, metastasis, and neuroendocrine differentiation (NED) via the miR-326/HNRNPA2B1 axis in vitro or in vivo [52]. Here, PCAT6 is linked to posterior cortical atrophy.